4//SEC Filing
PHILLIPS BARCLAY A 4
Accession 0001562180-18-004597
CIK 0001560241other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 7:16 PM ET
Size
12.9 KB
Accession
0001562180-18-004597
Insider Transaction Report
Form 4
PHILLIPS BARCLAY A
SVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2018-11-15$19.46/sh+5,000$97,300→ 5,000 total - Exercise/Conversion
Stock Options (Right to Buy)
2018-11-15−5,000→ 95,000 totalExercise: $19.46Exp: 2027-12-06→ Common Stock (5,000 underlying) - Sale
Common Stock
2018-11-15$39.92/sh−5,000$199,591→ 0 total
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price represents the weighted average price with a low of $39.35 and a high of $40.32. The Reporting Person undertakes to provide G1 Therapeutics, Inc., any security holder of G1 Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote 2 to this Form 4.
- [F3]The shares underlying this option will vest as to 25% of the shares on the first anniversary of the commencement of the Reporting Person's employment (which began on November 13, 2017) and as to an additional 1/48th of the shares monthly thereafter, subject to the Reporting Person's continued service through the applicable vesting dates.
Issuer
G1 Therapeutics, Inc.
CIK 0001560241
Entity typeother
Related Parties
1- filerCIK 0001265801
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 7:16 PM ET
- Size
- 12.9 KB